Zytiga Clinical Trials
Here are the 6 most popular medical studies for zytiga
Corticosteroid
Prednisone +1 More for Prostate Cancer
Recruiting3 awardsPhase 2
Los Angeles, California
This phase II trial studies how well giving abiraterone acetate and prednisone with or without dasatinib works in treating patients with metastatic, hormone-resistant prostate cancer. Androgens can cause the growth of prostate cancer cells. Antihormone therapy, such as abiraterone acetate, may lessen the amount of androgens made by the body. Dasatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet known whether abiraterone acetate and prednisone is more effective than abiraterone acetate, prednisone, and dasatinib in treating prostate cancer
Corticosteroid
Abiraterone + Prednisone for Prostate Cancer
Recruiting1 awardPhase 2
Homewood, Alabama
This trial will investigate whether adding abiraterone acetate + prednisone to the current standard of care (GnRH) can prolong the time until cancer growth is evident, as well as collecting safety information about this combination therapy.
Androgen Receptor Antagonist
ARN-509 +/− Abiraterone for Prostate Cancer
Recruiting1 awardPhase 2
New Brunswick, New Jersey
This trial is testing a new combo of drugs for high-risk prostate cancer patients undergoing surgery. The drugs lower androgen levels, which can cause prostate cancer growth. Prednisone may either kill the tumor cells or stop them from dividing.
Popular filter options for zytiga trials
Phase 3 Clinical Trials
View 64 phase 3 medical studies.
Corticosteroid
Apalutamide + Abiraterone Acetate + Prednisone for Prostate Cancer
Recruiting1 awardPhase 3
Phoenix, Arizona
This trial will compare the effectiveness of two treatments for metastatic castration-resistant prostate cancer: apalutamide with abiraterone acetate and prednisone, versus abiraterone acetate and prednisone alone.
LHRH Agonist
ADT + Abiraterone Acetate + Prednisone + Apalutamide for Prostate Cancer
Recruiting2 awardsPhase 3
Boston, Massachusetts
This trial is for prostate cancer patients who have received radiation and hormonal therapy, whose PSA is still detectable, and have received 6-12 months of hormonal therapy. The study drugs are LHRHA, Abiraterone Acetate, Apalutamide, and Prednisone.
Clinical Trials With No Placebo
View 64 medical studies that do not have a placebo group.
Steroidogenesis Inhibitor
Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer
Recruiting1 awardPhase < 1
Tampa, Florida
This trial will test whether an on and off schedule of taking abiraterone can prolong a cancer's response to the drug and help patients maintain their quality of life.
View More Zytiga Trials
See another 46 medical studies focused on zytiga.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.